EUVIMEDEUVIMED entdecken
Fallbericht

Primary Gliosarcoma With Mesenchymal Differentiation Resembling Follicular Dendritic Cell Sarcoma

Jing Zhou, Sha Zhao, Hai Li, Shudong Yang, Minhong Pan

Neuropathology · 2026-06 · 46 (3)

DOI: 10.1111/neup.70060 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neuropathology, online erschienen am 08.05.2026. Verfasst von Jing Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center of Nanjing Medical University and W…. Hauptthemen laut MEDLINE: Gliosarcoma, Brain Neoplasms, Dendritic Cell Sarcoma, Follicular. Die Arbeit nennt 19 Literaturangaben. Gefördert von: 2025 "Wild Goose Array Talents" Discipline Leader Fund of Wuxi People's Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliosarcoma of the central nervous system (CNS) is a rare and aggressive neoplasm exhibiting biphasic differentiation into glial and mesenchymal components. We report a primary gliosarcoma with mesenchymal differentiation resembling follicular dendritic cell sarcoma (FDCS). A 72‐year‐old man presented with a rim‐enhancing lesion in the left frontotemporal parenchyma. Histologically, the tumor was biphasic, comprising a glioblastoma (GBM) component of diffusely infiltrative GFAP‐ and Olig2‐positive oligodendroglial‐like cells with microvascular proliferation, and an FDCS component composed of cohesive sheets, nests, and fascicles of CD21‐, CD23‐, and CD35‐positive plump spindle cells. NGS analysis performed on the microdissected components revealed shared PTEN p.N48S mutations with high variant allele frequencies and MGMT promoter methylation, suggesting a monoclonal origin. Furthermore, the two components exhibited divergent genetic profiles: the glial component was characterized by an FGFR1 mutation, PDGFRA fusion, KIT/KDR amplification, and a whole‐arm 1p/19q codeletion, whereas the sarcomatous component harbored an ERBB4 p.S853F mutation. These alterations predominantly converged on the RAS‐MAPK and PI3K‐AKT‐mTOR signaling pathways. No IDH1/2 mutations, EGFR gene amplification, or TERT promoter mutations were detected in either component. This case represents the first documented instance of primary gliosarcoma with FDCS differentiation, thereby expanding its known differentiation spectrum. Furthermore, it demonstrates the necessity of separately analyzing each histological component in the diagnosis of challenging cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliosarcomaBrain NeoplasmsDendritic Cell Sarcoma, FollicularHumansMaleAgedCell DifferentiationDiagnosis, Differential

Stichwörter der Autor:innen

MGMT methylationPTEN mutationfollicular dendritic cell sarcomagliosarcomamolecular pathology

Autor:innen und Institutionen

  • Department of Pathology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Medical Center of Nanjing Medical University and Wuxi People's Hospital, Wuxi, China.
  • Department of Pathology, The First Affiliated Hospital with Nanjing Medical University/Jiangsu Province Hospital, Nanjing, China.

Förderung

  • 2025 "Wild Goose Array Talents" Discipline Leader Fund of Wuxi People's Hospital

Zitieren

APA

Zhou, J., Zhao, S., Li, H., Yang, S., & Pan, M. (2026). Primary Gliosarcoma With Mesenchymal Differentiation Resembling Follicular Dendritic Cell Sarcoma. Neuropathology, 46(3). https://doi.org/10.1111/neup.70060

Vancouver

Zhou J, Zhao S, Li H, Yang S, Pan M. Primary Gliosarcoma With Mesenchymal Differentiation Resembling Follicular Dendritic Cell Sarcoma. Neuropathology. 2026;46(3). doi:10.1111/neup.70060

BibTeX
@article{Zhou2026,
  author = {Zhou, Jing and Zhao, Sha and Li, Hai and Yang, Shudong and Pan, Minhong},
  title = {Primary Gliosarcoma With Mesenchymal Differentiation Resembling Follicular Dendritic Cell Sarcoma},
  journal = {Neuropathology},
  year = {2026},
  volume = {46},
  number = {3},
  doi = {10.1111/neup.70060}
}
Kostenlos starten →